Nektar Therapeutics (NKTR) Capital Expenditures (2010 - 2026)
Nektar Therapeutics' Capital Expenditures came in at $94,000 for Q2 2026, up 154.1% from $37,000 a year earlier and up 422.2% from the prior quarter.
Powered by 
Analysis
Nektar Therapeutics (NKTR) Capital Expenditures (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Nektar Therapeutics reported Capital Expenditures of $244,000, down 79.0% year-over-year; for FY2025, it was $171,000, down 88.4% from FY2024.
- Capital Expenditures carries a five-year compound annual growth rate of -52.7% (FY2020 to FY2025).
- Going back by year, Capital Expenditures was $1.47 million in FY2024 (+69.7%), $865,000 in FY2023 (-84.8%), $5.68 million in FY2022 (-62.1%) and $14.99 million in FY2021 (+106.5%).
- The five-year range for quarterly Capital Expenditures is $2,000 (Q1 2025) to $5.9 million (Q4 2021).
- Year-over-year, Capital Expenditures increased in three of the last seven quarters, with growth averaging 98.6%.
- The fastest year-over-year change in Capital Expenditures over five years came in Q1 2026 (growth of 800.0%), and the weakest in Q1 2025 (a decline of 98.7%).
- Business Quant data shows NKTR's Capital Expenditures at $18,000 (Q1 2026), $18,000 (Q4 2025) and $114,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 1.32 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 322.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 893.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -321.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -763.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 513.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 140.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 533.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 112.20 Mn |
| 10 | Nektar Therapeutics | 2.00 Bn | 232.24 Mn | - | 94,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 94,000.00 |
| Mar 31, 2026 | 18,000.00 |
| Dec 31, 2025 | 18,000.00 |
| Sep 30, 2025 | 114,000.00 |
| Jun 30, 2025 | 37,000.00 |
| Mar 31, 2025 | 2,000.00 |
| Dec 31, 2024 | 459,000.00 |
| Sep 30, 2024 | 666,000.00 |
| Jun 30, 2024 | 186,000.00 |
| Mar 31, 2024 | 157,000.00 |
| Dec 31, 2023 | 237,000.00 |
| Sep 30, 2023 | 33,000.00 |
| Jun 30, 2023 | 162,000.00 |
| Mar 31, 2023 | 433,000.00 |
| Dec 31, 2022 | 512,000.00 |
| Sep 30, 2022 | 181,000.00 |
| Jun 30, 2022 | 780,000.00 |
| Mar 31, 2022 | 4.20 Mn |
| Dec 31, 2021 | 5.90 Mn |
| Sep 30, 2021 | 2.94 Mn |
API Access
Nektar Therapeutics Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=NKTR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "NKTR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=NKTR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();